122 related articles for article (PubMed ID: 27698251)
1. Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.
Kammerer S; Jahn SW; Winter E; Eidenhammer S; Rezania S; Regitnig P; Pichler M; Schreibmayer W; Bauernhofer T
J Clin Pathol; 2016 Dec; 69(12):1116-1121. PubMed ID: 27698251
[TBL] [Abstract][Full Text] [Related]
2. KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Kammerer S; Sokolowski A; Hackl H; Platzer D; Jahn SW; El-Heliebi A; Schwarzenbacher D; Stiegelbauer V; Pichler M; Rezania S; Fiegl H; Peintinger F; Regitnig P; Hoefler G; Schreibmayer W; Bauernhofer T
Oncotarget; 2016 Dec; 7(51):84705-84717. PubMed ID: 27835900
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of analytical accuracy of HER2 status in patients with breast cancer: Comparison of HER2 GPA with HER2 IHC and HER2 FISH.
Jensen SG; Thomas PE; Christensen IJ; Balslev E; Hansen A; Høgdall E
APMIS; 2020 Nov; 128(11):573-582. PubMed ID: 32860265
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.
Rezania S; Kammerer S; Li C; Steinecker-Frohnwieser B; Gorischek A; DeVaney TT; Verheyen S; Passegger CA; Tabrizi-Wizsy NG; Hackl H; Platzer D; Zarnani AH; Malle E; Jahn SW; Bauernhofer T; Schreibmayer W
BMC Cancer; 2016 Aug; 16():628. PubMed ID: 27519272
[TBL] [Abstract][Full Text] [Related]
5. Detection of c-erbB-2 mRNAs using dig-labelled oligonucleotide probe with in situ hybridisation in human breast carcinoma: comparison with immunohistochemical results.
Oztürk M; Bolkent S; Yilmazer S; Kaner G; Unal H
Anal Cell Pathol; 1998; 16(4):201-9. PubMed ID: 9762367
[TBL] [Abstract][Full Text] [Related]
6. Estrogen Receptor-α Quantification in Breast Cancer: Concordance Between Immunohistochemical Assays and mRNA-In Situ Hybridization for ESR1 Gene.
Thomsen C; Nielsen S; Nielsen BS; Pedersen SH; Vyberg M
Appl Immunohistochem Mol Morphol; 2020; 28(5):347-353. PubMed ID: 30920963
[TBL] [Abstract][Full Text] [Related]
7. Divisional role of quantitative HER2 testing in breast cancer.
Yamamoto-Ibusuki M; Yamamoto Y; Fu P; Yamamoto S; Fujiwara S; Honda Y; Iyama K; Iwase H
Breast Cancer; 2015 Mar; 22(2):161-71. PubMed ID: 23604955
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterisation of GIRK1 variants resulting from alternative RNA editing of the KCNJ3 gene transcript in a human breast cancer cell line.
Wagner V; Stadelmeyer E; Riederer M; Regitnig P; Gorischek A; Devaney T; Schmidt K; Tritthart HA; Hirschberg K; Bauernhofer T; Schreibmayer W
J Cell Biochem; 2010 Jun; 110(3):598-608. PubMed ID: 20512921
[TBL] [Abstract][Full Text] [Related]
9. Detection of MET mRNA in gastric cancer in situ. Comparison with immunohistochemistry and sandwich immunoassays.
Schmid E; Klotz M; Steiner-Hahn K; Konen T; Frisk AL; Schatz C; Krahn T; von Ahsen O
Biotech Histochem; 2017; 92(6):425-435. PubMed ID: 28836864
[TBL] [Abstract][Full Text] [Related]
10. Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.
Pu T; Guo P; Qiu Y; Chen S; Yang L; Sun L; Ye F; Bu H
Int J Clin Exp Pathol; 2015; 8(9):10565-74. PubMed ID: 26617766
[TBL] [Abstract][Full Text] [Related]
11. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma.
Jung YY; Yoo JH; Park ES; Kim MK; Lee TJ; Cho BY; Chung YJ; Kang KH; Ahn HY; Kim HS
Pathol Res Pract; 2015 Feb; 211(2):162-70. PubMed ID: 25468810
[TBL] [Abstract][Full Text] [Related]
13. Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer.
Stocker A; Trojan A; Elfgen C; Hilbers ML; Moskovszky L; Varga Z
Breast Cancer Res Treat; 2020 Sep; 183(2):311-319. PubMed ID: 32638236
[TBL] [Abstract][Full Text] [Related]
14. Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients.
Murawski M; Woźniak M; Duś-Szachniewicz K; Kołodziej P; Rzeszutko M; Ziółkowski P
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110764
[TBL] [Abstract][Full Text] [Related]
15. A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study.
Hicks DG; Buscaglia B; Goda H; McMahon L; Natori T; Turner B; Soukiazian A; Okada H; Nakano Y
BMC Cancer; 2018 Dec; 18(1):1266. PubMed ID: 30563489
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
17. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry.
Pauletti G; Dandekar S; Rong H; Ramos L; Peng H; Seshadri R; Slamon DJ
J Clin Oncol; 2000 Nov; 18(21):3651-64. PubMed ID: 11054438
[TBL] [Abstract][Full Text] [Related]
18. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
[TBL] [Abstract][Full Text] [Related]
19. HER2 status determination using RNA-ISH--a rapid and simple technique showing high correlation with FISH and IHC in 141 cases of breast cancer.
Alba J; Gutierrez J; Coupe VM; Fernández B; Vázquez-Boquete Á; Alba J; Forteza J; García-Caballero T
Histol Histopathol; 2012 Aug; 27(8):1021-7. PubMed ID: 22763874
[TBL] [Abstract][Full Text] [Related]
20. Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.
Lim SJ; Cantillep A; Carpenter PM
Hum Pathol; 2013 Nov; 44(11):2590-6. PubMed ID: 24075600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
